BCEIE › News › EPIGRAL

Order win

Epigral wins order worth ₹28.11 crore

Epigral (BSE: EPIGRAL) said it has received an order valued at ₹28.11 crore. The company is valued at about ₹3,914 crore.

BCEIE News Desk · Published 29 Oct 2026, 07:11 pm IST · Filing received 29 Oct 2026, 06:55 pm IST

What happened

Epigral (BSE: EPIGRAL) informed the stock exchanges on 29 October 2026 at 06:55 PM that it has received an order valued at ₹28.11 crore.

From the filing: "Intimation of assessment order for A.Y. 2023-24 pertaining to F.Y. 2022-23, along with notice of demand of Rs.28.11 crore (including applicable interest)."

How big is it?

At ₹28.11 crore, the order is equal to about 0.7% of the company's market value of ₹3,914 crore and 1.1% of its revenue over the last four reported quarters (₹2,626 crore).

Relative to the company's annual revenue, it is a modest addition.

Company snapshot

Epigral is a small-cap company, with a market value of about ₹3,914 crore.

The stock last traded at ₹907.3, against a 52-week range of ₹807–₹1,729.9 (47.5% below the high).

Before this filing the shares had moved −14.9% over the month and −22.9% over three months. Average daily turnover over the last 20 sessions was about ₹3.97 crore.

Promoters held 68.83% at the end of Q1 FY27. Foreign institutions owned 1.03% and domestic institutions 5.56%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY26607160.737.25
Q2 FY2658751.211.87
Q3 FY2659739.19.07
Q4 FY267368118.76
Q1 FY2770599.723.12

What history shows

BCEIE has no earlier order win filing from this company on record since May 2026.

Market-wide, 2,064 order win filings with an impact score of 50 or more saw an average next-day move of +0.8%, with 53% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Execution progress and revenue recognition from this order in the coming quarters.
  • 2 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.